Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merg
BD Partners With Waters to Build High-Volume Diagnostics Leader
10:16am, Tuesday, 15'th Jul 2025
BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.
Becton Dickinson gets its spinoff deal, but the stock is still falling
07:48am, Monday, 14'th Jul 2025
Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.
Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
04:15pm, Monday, 07'th Jul 2025
FRANKLIN LAKES, N.J. , July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin ha
Buy 3 IDEAL Dividend Kings Of 25 'Safer' In July's 55
05:37am, Friday, 04'th Jul 2025
Most Dividend Kings are overpriced, but six currently offer fair value, with annual dividends from $1,000 invested exceeding their share prices. Top-yielding Dividend Kings like Altria, Northwest Natu
3 Undervalued Dividend King Stocks With Over 50% Upside Potential
09:47pm, Tuesday, 01'st Jul 2025
As we enter the second half of 2025, now is the perfect time to invest in dividend stocks — especially those with quality underlying fundamentals that pay high dividend yields.
Best Dividend Aristocrats For July 2025
07:19am, Sunday, 29'th Jun 2025
Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa
Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now
08:33am, Wednesday, 25'th Jun 2025
Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting until
Best Dividend Kings: June 2025
08:49am, Tuesday, 24'th Jun 2025
Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a c
Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)
04:48pm, Monday, 09'th Jun 2025
Becton, Dickinson and Company (NYSE:BDX ) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 2:00 PM ET Company Participants Thomas E. Polen - President, CEO & Chairman Conference Cal
Becton, Dickinson: A Dividend King Facing Challenges Offers Value
11:44am, Monday, 09'th Jun 2025
Becton, Dickinson is significantly undervalued, trading at 12.3x earnings with a 2.5% dividend yield, the highest in a decade. The company boasts a 53-year streak of dividend growth, excellent dividen
June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss
07:00am, Saturday, 07'th Jun 2025
Despite bubble fears, 91% of market gains since 2009 are justified by fundamentals like earnings, dividends, and strong balance sheets. Stocks appear overvalued at face value, but strong long-term ear
June's Dividend Kings: 3 Ideal Buys In 25 "Safer" Dogs
08:13am, Wednesday, 04'th Jun 2025
Most Dividend Kings are currently overpriced, but six offer fair value where annual dividends from $1,000 invested exceed their share price. Three top-yield Dividend Kings—Altria, Northwest Natural,
BD Stock Might See Short-term Decline After Warning on Tamponade Tubes
11:16am, Friday, 30'th May 2025
BDX warns of safety risks tied to its esophagogastric balloon tamponade tubes after one death and two injuries, prompting updated usage instructions for clinicians.
